The Use of REZUM System in Chinese Male Patients With LUTS Secondary to Benign Prostate Enlargement
NCT04340934 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3
Last updated 2021-06-04
Summary
Men with enlarged prostates commonly experience lower urinary tract symptoms and may go on to develop complications such as acute urinary retention (AUR). Surgery is the standard treatment option required to remove the enlarged prostates and to rectify such complications. Transurethral resection of prostate (TURP) was first performed over 80 years ago and is still regarded as the "gold standard" for the treatment of benign prostatic enlargement (BPE) in prostates between 30 and 80ml. While TURP results in an improvement in symptoms, perioperative morbidity and long-term complications can include postoperative bleeding, urinary retention, incontinence, urethral strictures, erectile dysfunction, and ejaculatory dysfunction. Rezūm is a system uses water steam energy to remove the particular part of the prostate that enlarges and causes symptoms due to BPH. Rezum involves a radiofrequency (RF) generator system and an endoscopic device that is introduced into the body via the urethra. Radiofrequency energy from the generator will heat up a controlled amount of water inside the system and converting the water into vapour or steam. The thermal energy created outside the body is delivered into the prostate tissue through the tiny needle at the tip of the endoscopic device. Small amount of steam will then be injected into the tissue and energy will be released during the conversion of steam to water. The energy will heat up the prostate tissue and result in gradually removal of the targeted obstructive prostate tissue. The treatment procedure takes approximately 3-7 minutes and can be performed as day surgery. No radiofrequency energy is delivered into the body, other than the prostate. Throughout the procedure normal saline (salty water) is running into the urethra through the scope to help ensure better views and to prevent the urethra from overheating. Voiding symptom will gradually improve after the procedure. From clinical study based in Caucasian population, patients had improved urinary flow rate by on average 50% and also improvement in quality of life scores. The treatment results could last for at least 4 years. However, information regarding the use of Rezum in Chinese and Asian is lacking. This study is proposed to evaluate the efficacy and safety of Rezum in our population.
Conditions
- Benign Prostatic Hyperplasia
Interventions
- DEVICE
-
REZUM system
Rezūm is a system uses water steam energy to remove the particular part of the prostate that enlarges and causes symptoms due to BPH. Rezum involves a radiofrequency (RF) generator system and an endoscopic device that is introduced into the body via the urethra.
Sponsors & Collaborators
-
Chinese University of Hong Kong
lead OTHER
Principal Investigators
-
Chi Fai NG, MD · Chinese University of Hong Kong
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 50 Years
- Max Age
- 80 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-05-13
- Primary Completion
- 2021-01-29
- Completion
- 2021-01-29
Countries
- Hong Kong
Study Locations
More Related Trials
-
Comparative Study Between Rezum and Tamsulosin
NCT07169773 ·Status: COMPLETED ·Phase: NA
-
Ultrasound-Guided Photoselective Vaporization of the Prostate
NCT02346500 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
The Association of Baseline Characteristics of Male Patients Presented With LUTS and Long Term Clinical Outcomes
NCT04764903 ·Status: COMPLETED
-
Catheterless Water Vapor Therapy for the Treatment of BPH
NCT04997369 ·Status: SUSPENDED ·Phase: NA
-
Real World Data on Management of Male LUTS
NCT03075449 ·Status: COMPLETED
-
REZŪM vs. Dual Drug Therapy for Symptomatic Benign Prostatic Hyperplasia in Sexually Active Men
NCT04838769 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Implanted Nitinol Device (iTind) System in Chinese Males With Lower Urinary Tract Symptom Secondary to BPH
NCT05440981 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Optilume BPH Catheter System and the Rezum Water Vapor Therapy in Treating Benign Prostatic Hyperplasia
NCT06769997 ·Status: RECRUITING ·Phase: NA
-
Innovative Minimally Invasive Options in Treatment of Urinary Problems Related to Prostate Enlargement (BPH) in Men
NCT03043222 ·Status: WITHDRAWN ·Phase: NA
-
Outcomes of Water Vapor Thermal Therapy (REZUM) in Management of Symptomatic Patients With Benign Prostatic Enlargement
NCT05784909 ·Status: UNKNOWN ·Phase: NA
-
Perioperative Tamsulosin for Treating Voiding Dysfunction Following Prostate Biopsy
NCT07276919 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Modified Water Vapor Thermal Therapy in Management of Patients With Large-volume Benign Prostatic Hyperplasia
NCT06596590 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Randomized Trial Comparing Terazosin 5 mg Daily and Doxazosin GITS 4 mg Daily for Trial Without Catheter in Acute Urinary Retention With Long Term Follow up
NCT00563485 ·Status: TERMINATED ·Phase: NA
-
Comparing UroLift Experience Against Rezūm
NCT04338776 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
RT-310 Dose Escalation BPH Study
NCT06136819 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
The Spanner Prostatic Stent and Patient's Quality of Life
NCT01705444 ·Status: COMPLETED ·Phase: NA
-
BOTOX in Men With Prostate Cancer With Lower Urinary Tract Symptoms(LUTS)/Benign Prostatic Hyperplasia (BPH)
NCT01520441 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
The Clinical Efficacy of Rezūm Therapy Versus Bipolar Trans-urethral Resection of the Prostate for Treatment Benign Prostatic Hyperplasia
NCT06116370 ·Status: COMPLETED ·Phase: NA
-
IIT-2022-Simultaneous Urolift™ and Median Lobe Enucleation
NCT06157164 ·Status: TERMINATED
-
Study of PRX302 for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia (BPH)
NCT01454349 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Randomized Trial Comparing Alfuzosin GITS 10 mg Daily With Placebo for Trial Without Catheter in Acute Urinary Retention With Long Term Follow up
NCT00563654 ·Status: TERMINATED ·Phase: NA
-
The Combined Effect of Intravesical Botox Injections and HoLEP Surgery in Treating Benign Prostatic Hyperplasia and Overactive Bladder
NCT05393921 ·Status: WITHDRAWN ·Phase: PHASE4
-
Effect of Enhanced External Counterpulsation on Lower Urinary Tract Symptoms
NCT01815697 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of the Functional Outcomes After Bilateral, 3D Ultrasound-guided Focal Thermal Ablation of the Prostate Transition Zone, in Patients with Benign Prostatic Hyperplasia-related Obstruction
NCT06212453 ·Status: RECRUITING ·Phase: PHASE2
-
BETTY: BEnign Prostatic Hyperplasia Transperineal Targeted Microwave therapY
NCT05443451 ·Status: RECRUITING ·Phase: NA